ES2032887T3 - Metodo para preparar emulsiones acuosas fluoroquimicas, estables y concentradas. - Google Patents

Metodo para preparar emulsiones acuosas fluoroquimicas, estables y concentradas.

Info

Publication number
ES2032887T3
ES2032887T3 ES198888104014T ES88104014T ES2032887T3 ES 2032887 T3 ES2032887 T3 ES 2032887T3 ES 198888104014 T ES198888104014 T ES 198888104014T ES 88104014 T ES88104014 T ES 88104014T ES 2032887 T3 ES2032887 T3 ES 2032887T3
Authority
ES
Spain
Prior art keywords
emulsion
stable
concentrated water
water emulsions
surgical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888104014T
Other languages
English (en)
Inventor
Frank Kenneth Schweighardt
Charles Randall Kayhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Products and Chemicals Inc
Original Assignee
Air Products and Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Products and Chemicals Inc filed Critical Air Products and Chemicals Inc
Application granted granted Critical
Publication of ES2032887T3 publication Critical patent/ES2032887T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SE HA DEMOSTRADO QUE UNA EMULSION ACUOSA ESTABLE, CONCENTRADA DE UN PRODUCTO QUIMICO PERFLUORADO, UN FOSFOLIPIDO Y UN TRIGLICERIDO DE ACIDOS GRASOS TIENE UNA ESTABILIDAD AUMENTADA, TAMAÑO DE PARTICULA DISMINUIDO Y TOLERANCIA MEJORADA A SISTEMAS BIOLOGICOS. LA EMULSION TIENE UTILIDAD COMO MEDIO DE TRANSPORTE DE OXIGENO, TAL COMO EN SANGRE ARTIFICIAL. LA EMULSION PUEDE INCLUIR OPCIONALMENTE EMULSIFICADORES DE ADICION DEL AGENTE TENSIOACTIVO SURFINOL SE Y AGENTE TENSIOACTIVO PLURONIC P-105. LA EMULSION SE PREPARA USANDO UNA TECNICA DE EMULSIFICACION MEJORADA.
ES198888104014T 1987-03-20 1988-03-14 Metodo para preparar emulsiones acuosas fluoroquimicas, estables y concentradas. Expired - Lifetime ES2032887T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/028,521 US4895876A (en) 1987-03-20 1987-03-20 Concentrated stable fluorochemical aqueous emulsions containing triglycerides

Publications (1)

Publication Number Publication Date
ES2032887T3 true ES2032887T3 (es) 1993-03-01

Family

ID=21843917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888104014T Expired - Lifetime ES2032887T3 (es) 1987-03-20 1988-03-14 Metodo para preparar emulsiones acuosas fluoroquimicas, estables y concentradas.

Country Status (10)

Country Link
US (1) US4895876A (es)
EP (1) EP0282949B1 (es)
JP (1) JPS63264521A (es)
KR (1) KR900006830B1 (es)
BR (1) BR8801157A (es)
CA (1) CA1312011C (es)
DE (1) DE3871195D1 (es)
ES (1) ES2032887T3 (es)
MX (1) MX169411B (es)
ZA (1) ZA881953B (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US5684050A (en) * 1986-01-24 1997-11-04 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5514720A (en) * 1986-07-09 1996-05-07 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US4781676A (en) * 1987-02-20 1988-11-01 Air Products And Chemicals, Inc. Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
US5171755A (en) * 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
JPH0372423A (ja) * 1989-05-26 1991-03-27 Green Cross Corp:The パーフルオロカーボン化合物含有乳化製剤
EP0440925A1 (en) * 1989-12-13 1991-08-14 The Green Cross Corporation Internal organ-preserving liquid and method for preserving internal organs
US20020150539A1 (en) * 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
AU648100B2 (en) * 1990-09-03 1994-04-14 Unilever Plc Hair treatment composition
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5146014A (en) * 1991-07-02 1992-09-08 Air Products And Chemicals, Inc. Perfluoroethyldimethyl cyclohexane
FR2679150A1 (fr) * 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
AU2441592A (en) * 1991-08-08 1993-03-02 Leigh D. Segel Fluorocarbon blood substitute
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
HU218018B (hu) * 1991-09-17 2000-05-28 Sonus Pharmaceuticals Inc. Gázos ultrahang-kontrasztanyag és eljárás ultrahang kontrasztanyaghoz megfelelő gázok kiválasztására
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US5304325A (en) * 1991-11-13 1994-04-19 Hemagen/Pfc Emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use
DE69226372T2 (de) * 1991-11-14 1999-04-01 Alliance Pharmaceutical Corp., San Diego, Calif. Vorrichtung zur teilweisen flüssigen beatmung mit fluorkohlenwasserstoffen
US5403575A (en) * 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
GB9204509D0 (en) * 1992-03-02 1992-04-15 Unilever Plc Hair care composition
US5628930A (en) * 1992-10-27 1997-05-13 Alliance Pharmaceutical Corp. Stabilization of fluorocarbon emulsions
US5595687A (en) 1992-10-30 1997-01-21 Thomas Jefferson University Emulsion stability
US5420359A (en) * 1992-12-11 1995-05-30 Minnesota Mining And Manufacturing Company Chlorofluoroether compositions and preparation thereof
HUT72323A (en) * 1993-01-25 1996-04-29 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
US5635538A (en) * 1993-03-16 1997-06-03 Alliance Pharmaceutical Corp. Fluorocarbon emulsions with reduced pulmonary gas-trapping properties
US5969004A (en) * 1993-10-15 1999-10-19 The Gillette Company Aqueous inks
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6521211B1 (en) * 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US5726209A (en) * 1995-06-07 1998-03-10 Alliance Pharmaceutical Corp. Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir
US5611344A (en) * 1996-03-05 1997-03-18 Acusphere, Inc. Microencapsulated fluorinated gases for use as imaging agents
US5837221A (en) * 1996-07-29 1998-11-17 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US20050019266A1 (en) * 1997-05-06 2005-01-27 Unger Evan C. Novel targeted compositions for diagnostic and therapeutic use
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
EP1365068B1 (en) * 2002-05-10 2008-05-07 The Procter & Gamble Company Embossed tissue having loosened surface fibers and method for its production
GB0319500D0 (en) * 2003-08-19 2003-09-17 Resolution Chemicals Ltd Particle-size reduction apparatus,and use thereof
US8012457B2 (en) * 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US20070149617A1 (en) 2005-11-14 2007-06-28 Deckelbaum Richard J Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
AU2007249200B2 (en) * 2006-05-15 2013-12-19 Virginia Commonwealth University Methods and compositions for controlled and sustained production and delivery of peroxides
WO2008036353A2 (en) 2006-09-19 2008-03-27 The Trustees Of Columbia University In The City Of New York Omega-3 diglyceride emulsions
US8618056B2 (en) 2007-12-22 2013-12-31 Cuthbert O. Simpkins Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
CN102105054A (zh) * 2008-07-18 2011-06-22 氧生物治疗有限公司 治疗创伤性脑损伤的方法
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
CN102395548A (zh) * 2009-04-15 2012-03-28 奥斯金生医公司 全氟化碳类乳液
SG183878A1 (en) * 2010-03-19 2012-10-30 Oxygen Biotherapeutics Inc Perfluorocarbon eye cream formulations
WO2012096697A1 (en) * 2011-01-14 2012-07-19 Simpkins Cuthbert O Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US20120196270A1 (en) * 2011-02-02 2012-08-02 Sangart, Inc. Methods for preserving an organ for transplantation using a hemoglobin-carbon monoxide complex
CN105263321B (zh) * 2013-03-28 2018-07-27 哥伦比亚大学纽约管理委员会 用omega-3甘油酯再灌注促进对用于移植的供体器官的保护
WO2024046999A1 (de) 2022-08-31 2024-03-07 Johann Wolfgang Goethe-Universität Frankfurt am Main Lecithin-modifizierte nanoskalierte sauerstoffträger (lenox)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5331209B2 (es) * 1973-10-05 1978-09-01
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
JPS5331208A (en) * 1976-09-02 1978-03-24 Matsushita Electric Ind Co Ltd Lubricator for closed compressor and the like
JPS5924132B2 (ja) * 1980-12-02 1984-06-07 株式会社 林原生物化学研究所 栄養補給用乳剤の製法
US4533254A (en) * 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
US4443480A (en) * 1982-04-12 1984-04-17 Children's Hospital Medical Center Artificial blood and other gas transport agents
US4423077A (en) * 1982-07-27 1983-12-27 The University Of Pennsylvania Perfluorochemical emulsion artificial blood
US4397870A (en) * 1982-07-27 1983-08-09 The University Of Pennsylvania Process for prolonging retention of emulsion particles in the bloodstream
US4497829A (en) * 1982-07-27 1985-02-05 The University Of Pennsylvania Process for preparing perfluorochemical emulsion artificial blood
JPS6033367A (ja) * 1983-08-04 1985-02-20 Nec Corp アルミニウムのドライエッチング方法
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
SE8505048L (sv) * 1985-10-25 1987-04-26 Nutritional Int Res Inst Nutritionsemulsion med syretransporterande egenskaper
DE3785054T2 (de) * 1986-01-24 1993-07-08 Childrens Hosp Medical Center Stabile emulsionen von stark fluorierten, organischen verbindungen.
US4781676A (en) * 1987-02-20 1988-11-01 Air Products And Chemicals, Inc. Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
US4866096A (en) * 1987-03-20 1989-09-12 Air Products And Chemicals, Inc. Stable fluorochemical aqueous emulsions

Also Published As

Publication number Publication date
US4895876A (en) 1990-01-23
KR900006830B1 (ko) 1990-09-22
BR8801157A (pt) 1988-10-18
CA1312011C (en) 1992-12-29
EP0282949A3 (en) 1989-08-09
EP0282949A2 (en) 1988-09-21
EP0282949B1 (en) 1992-05-20
DE3871195D1 (de) 1992-06-25
KR880010755A (ko) 1988-10-24
ZA881953B (en) 1989-11-29
MX169411B (es) 1993-07-02
JPS63264521A (ja) 1988-11-01

Similar Documents

Publication Publication Date Title
ES2053598T3 (es) Un metodo para preparar una emulsion acuosa estable de un producto quimico perfluorado.
CA1228812A (en) Process for the manufacture of novel topically administrable pharmaceutical compositions
ES431706A1 (es) Un procedimiento de preparacion de emulsiones de compuestosfluorados en agua o en soluciones salinas.
DE59002618D1 (de) Verfahren zur Herstellung einer Nanoemulsion von Oelpartikeln in einer wässrigen Phase.
GB9400981D0 (en) Preparation of microparticles
KR880010755A (ko) 고농도의 안정한 플루오로케미칼 수화 에멀션
SE8304143L (sv) Perfluorokemisk emulsion for artificiellt blod
BR9915963A (pt) Emulsão óleo em água cosmética ou para o cuidado pessoal, método de produção de uma emulsão, formulação de estabilizador de emulsificante de mistura seca, mistura seca, e, uso de uma combinação de polissacarìdeo, de um polissacarìdeo de xantano e de um polissacarìdeo de poliglucomanano
DE69306810D1 (de) Stabilisierung von fluorkohlenstoff-emulsionen
ES2002750A6 (es) Procedimiento de obtencion de composiciones en emulsion para la administracion parenteral ynu oral de farmacos hidrofobos ionizables, escasamente hidrosolubles.
BRPI0416044A (pt) sistema e método para distribuição transdérmica
DE69124109D1 (de) Gelbildende flüssigträger-zusammensetzung
DE50306384D1 (de) Mikro-emulsionen mit binärer phasen- und wirkstoffdifferenzierbarkeit, deren herstellung und deren verwendung, insbesondere zur topischen sauerstoffversorgung
DE69824164T2 (de) Arzneizubereitungen zur behandlung sexueller funktionsstörungen
NO173685B (no) Topisk haarvekstpreparat for behandling av vanlig skallethet hos menn
CA1169770A (en) Antimycotic agent, in the form of sticks, with a high release of active compound
ES2038435T3 (es) Microemulsion para uso cosmetico o farmaceutico.
ES2064801T3 (es) Emusion estable apropiada para la administracion farmaceutica, procedimiento para su obtencion, y emulsion para la aplicacion como medicamento.
DE68904999D1 (de) Verfahren zur herstellung dispergierbarer kolloidaler systeme aus amphiphilen lipiden in form von liposomen in submikrongroesse.
Kudo Experiments on the extrusion of polar filaments of cnidosporidian spores
UA72933C2 (uk) Спосіб приготування ветеринарної композиції для введення нерозчинного у воді лікарського засобу тварині за допомогою водорозподільної системи та суспоемульсія
JPH09309813A (ja) 皮膚外用剤
DE50209881D1 (de) Herstellung von dialysekonzentrat aus einer hochverdichteten konzentratvorstufe und vorrichtung zur anwendung am dialyseplatz.
DE60001096D1 (de) Lipidmembran zusammensetzungen
NZ332497A (en) Pharmaceutical composition having a carrier system containing a combination of an alkylene glycol and unsaturated fatty acid alcohol as the solvent and a stiffening agent

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 282949

Country of ref document: ES